Sjogren's syndrome is a chronic disease, primarily affecting women, with significant morbidity. Signs and symptoms of this disease often occur in the head and neck area. The identification and diagnosis of this disease is complicated by its multiorgan involvement, the presence of several sets of diagnostic criteria, and the lack of a single identifying test. However, there is the underlying theme that SS comprises three components: ocular, salivary, and systemic. The use of recently published criteria by the American-European consensus group is the current standard for the diagnosis of SS.
While there is no treatment available for the underlying pathogenesis of SS, there are useful treatments for symptom relief and complication prevention that can significantly stabilize or improve patients' quality of life.
1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61(6):554-558.
2. Derk CT, Vivino FB. A primary care approach to Sjögren's syndrome. Helping patients cope with sicca symptoms, extraglandular manifestations. Postgrad Med 2004; 116(3):49-54,59,65. http:// www.postgradmed.com/issues/2004/09_04/derk.html (accessed October 2005).
3. Cimaz R, Casadei A, Rose C, et al. Primary Sjögren's syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 2003; 162(10):661-665.
4. Pillemer SR, Brennan MT, Sankar V, et al. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Arthritis Rheum 2004; 51(4):601-604.
5. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch Intern Med 2004; 164(12):1275-1284.
6. Fox RI. Sjögren's syndrome. Lancet 2005; 366(9482):321-331.
7. Daniels TE, Wu AJ. Xerostomia—clinical evaluation and treatment in general practice. J Calif Dent Assoc 2000; 28(12):933-941. http://www.cda.org/cda_member/pubs/journal/jour1200/xero.html (accessed October 2005).
8. Freeman SR, Sheehan PZ, Thorpe MA, et al. Ear, nose, and throat manifestations of Sjögren's syndrome: retrospective review of a multidisciplinary clinic. J Otolaryngol 2005; 34(1):20-24.
9. Boki KA, Ioannidis JP, Segas JV, et al. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study. J Rheumatol 2001; 28(4): 798-801.
10. Ziavra N, Politi EN, Kastanioudakis I, et al. Hearing loss in Sjögren's syndrome patients. A comparative study. Clin Exp Rheumatol 2000; 18(6):725-728.
11. Vivino FB, Gala I, Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002; 29(5):938-944.
12. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004; 50(4):1262-1269.
Was this article helpful?
The term vaginitis is one that is applied to any inflammation or infection of the vagina, and there are many different conditions that are categorized together under this ‘broad’ heading, including bacterial vaginosis, trichomoniasis and non-infectious vaginitis.